caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1235493008

Kefah Al-RamahiM.D.

Internal MedicineHolyoke, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 077041
Home health agency
CCN 070025
Hospital
REFERRAL NETWORK

Where Kefah Al-Ramahi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
BANNER - UNIVERSITY MEDICAL CENTER TUCSON CAMPUS LLC1131
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
407
Unique beneficiaries
—
Total services
561
Distinct HCPCS
9
Medicare payment
$46K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 3,978 Internal Medicine providers in MA — above median (cohort median 564).
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
83.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
APM Entity
PRESCRIBING · PART D · 2024
Total Rx claims
5,897
Beneficiaries
—
Total drug cost
$527K
Distinct drugs
121
Brand share
17.9%
Top prescribed drugs
Amlodipine Besylate558 claims
Atorvastatin Calcium428 claims
Levothyroxine Sodium231 claims
Lisinopril224 claims
Rosuvastatin Calcium205 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.